APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indapamide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Indapamide Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchIndapamide Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Indapamide Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Indapamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indapamide Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Indapamide Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Indapamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Indapamide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Indapamide market include ANI Pharma, Apeloa Kangyu, Cigna, Glenmark Pharmaceuticals, Servier, Supra Chemicals, Taj Pharmaceuticals, Mylan and Shandong Yinfeida Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Indapamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Indapamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Indapamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Indapamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Indapamide Segment by Company

ANI Pharma

Apeloa Kangyu

Cigna

Glenmark Pharmaceuticals

Servier

Supra Chemicals

Taj Pharmaceuticals

Mylan

Shandong Yinfeida Pharmaceutical

Suzhou Lixinpharm

Teva

Lisheng Pharma

Indapamide Segment by Type

1.25 mg Indapamide Tablets

2.5 mg Indapamide Tablets

Indapamide Segment by Application

Diuretic

Hypertension Treatment

Other

Indapamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Indapamide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Indapamide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Indapamide significant trends, drivers, influence factors in global and regions.

6. To analyze Indapamide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indapamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indapamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indapamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Indapamide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Indapamide industry.

Chapter 3: Detailed analysis of Indapamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Indapamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Indapamide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Indapamide Industry Trends Table 2. Indapamide Industry Drivers Table 3. Indapamide Industry Opportunities and Challenges Table 4. Indapamide Industry Restraints Table 5. Global Indapamide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Indapamide Revenue Share by Company (2021-2026) Table 7. Global Indapamide Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global Indapamide Sales Volume Share by Company (2021-2026) Table 9. Global Indapamide Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Indapamide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Indapamide Key Company Manufacturing Base & Headquarters Table 12. Global Indapamide Company, Product Type & Application Table 13. Global Indapamide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Indapamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1.25 mg Indapamide Tablets Table 18. Significant Companies of 2.5 mg Indapamide Tablets Table 19. Global Indapamide Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global Indapamide Sales Volume by Type (2021-2026) & (K Tons) Table 21. Global Indapamide Sales Volume by Type (2027-2032) & (K Tons) Table 22. Global Indapamide Sales Volume Share by Type (2021-2026) Table 23. Global Indapamide Sales Volume Share by Type (2027-2032) Table 24. Global Indapamide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Indapamide Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Indapamide Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Indapamide Sales Value Share by Type (2021-2026) Table 28. Global Indapamide Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Diuretic Table 30. Significant Companies of Hypertension Treatment Table 31. Significant Companies of Other Table 32. Global Indapamide Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 33. Global Indapamide Sales Volume by Application (2021-2026) & (K Tons) Table 34. Global Indapamide Sales Volume by Application (2027-2032) & (K Tons) Table 35. Global Indapamide Sales Volume Share by Application (2021-2026) Table 36. Global Indapamide Sales Volume Share by Application (2027-2032) Table 37. Global Indapamide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Indapamide Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Indapamide Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Indapamide Sales Value Share by Application (2021-2026) Table 41. Global Indapamide Sales Value Share by Application (2027-2032) Table 42. Global Indapamide Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 43. Global Indapamide Sales by Region (2021-2026) & (K Tons) Table 44. Global Indapamide Sales Market Share by Region (2021-2026) Table 45. Global Indapamide Sales by Region (2027-2032) & (K Tons) Table 46. Global Indapamide Sales Market Share by Region (2027-2032) Table 47. Global Indapamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Indapamide Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Indapamide Sales Value Share by Region (2021-2026) Table 50. Global Indapamide Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Indapamide Sales Value Share by Region (2027-2032) Table 52. Global Indapamide Market Average Price (US$/Ton) by Region (2021-2026) Table 53. Global Indapamide Market Average Price (US$/Ton) by Region (2027-2032) Table 54. Global Indapamide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 55. Global Indapamide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Indapamide Sales by Country (2021-2026) & (K Tons) Table 57. Global Indapamide Sales Market Share by Country (2021-2026) Table 58. Global Indapamide Sales by Country (2027-2032) & (K Tons) Table 59. Global Indapamide Sales Market Share by Country (2027-2032) Table 60. Global Indapamide Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Indapamide Sales Value Market Share by Country (2021-2026) Table 62. Global Indapamide Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Indapamide Sales Value Market Share by Country (2027-2032) Table 64. ANI Pharma Company Information Table 65. ANI Pharma Business Overview Table 66. ANI Pharma Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. ANI Pharma Indapamide Product Portfolio Table 68. ANI Pharma Recent Development Table 69. Apeloa Kangyu Company Information Table 70. Apeloa Kangyu Business Overview Table 71. Apeloa Kangyu Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Apeloa Kangyu Indapamide Product Portfolio Table 73. Apeloa Kangyu Recent Development Table 74. Cigna Company Information Table 75. Cigna Business Overview Table 76. Cigna Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Cigna Indapamide Product Portfolio Table 78. Cigna Recent Development Table 79. Glenmark Pharmaceuticals Company Information Table 80. Glenmark Pharmaceuticals Business Overview Table 81. Glenmark Pharmaceuticals Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Glenmark Pharmaceuticals Indapamide Product Portfolio Table 83. Glenmark Pharmaceuticals Recent Development Table 84. Servier Company Information Table 85. Servier Business Overview Table 86. Servier Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Servier Indapamide Product Portfolio Table 88. Servier Recent Development Table 89. Supra Chemicals Company Information Table 90. Supra Chemicals Business Overview Table 91. Supra Chemicals Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Supra Chemicals Indapamide Product Portfolio Table 93. Supra Chemicals Recent Development Table 94. Taj Pharmaceuticals Company Information Table 95. Taj Pharmaceuticals Business Overview Table 96. Taj Pharmaceuticals Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Taj Pharmaceuticals Indapamide Product Portfolio Table 98. Taj Pharmaceuticals Recent Development Table 99. Mylan Company Information Table 100. Mylan Business Overview Table 101. Mylan Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Mylan Indapamide Product Portfolio Table 103. Mylan Recent Development Table 104. Shandong Yinfeida Pharmaceutical Company Information Table 105. Shandong Yinfeida Pharmaceutical Business Overview Table 106. Shandong Yinfeida Pharmaceutical Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio Table 108. Shandong Yinfeida Pharmaceutical Recent Development Table 109. Suzhou Lixinpharm Company Information Table 110. Suzhou Lixinpharm Business Overview Table 111. Suzhou Lixinpharm Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Suzhou Lixinpharm Indapamide Product Portfolio Table 113. Suzhou Lixinpharm Recent Development Table 114. Teva Company Information Table 115. Teva Business Overview Table 116. Teva Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Teva Indapamide Product Portfolio Table 118. Teva Recent Development Table 119. Lisheng Pharma Company Information Table 120. Lisheng Pharma Business Overview Table 121. Lisheng Pharma Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Lisheng Pharma Indapamide Product Portfolio Table 123. Lisheng Pharma Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Indapamide Distributors List Table 127. Indapamide Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Indapamide Product Image Figure 2. Global Indapamide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indapamide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Indapamide Sales (2021-2032) & (K Tons) Figure 5. Global Indapamide Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Indapamide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1.25 mg Indapamide Tablets Image Figure 10. 2.5 mg Indapamide Tablets Image Figure 11. Global Indapamide Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global Indapamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Indapamide Sales Volume Share by Type (2021-2032) Figure 14. Global Indapamide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Indapamide Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Indapamide Sales Value Share by Type (2021-2032) Figure 17. Diuretic Image Figure 18. Hypertension Treatment Image Figure 19. Other Image Figure 20. Global Indapamide Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 21. Global Indapamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Indapamide Sales Volume Share by Application (2021-2032) Figure 23. Global Indapamide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Indapamide Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Indapamide Sales Value Share by Application (2021-2032) Figure 26. Global Indapamide Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 27. Global Indapamide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Indapamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Indapamide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Indapamide Sales Value (2021-2032) & (US$ Million) Figure 31. North America Indapamide Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Indapamide Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Indapamide Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Indapamide Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Indapamide Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Indapamide Sales Value (2021-2032) & (US$ Million) Figure 37. South America Indapamide Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Indapamide Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Indapamide Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Indapamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Indapamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Indapamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Indapamide Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Indapamide Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 1.25 mg Indapamide Tablets
  • 2.5 mg Indapamide Tablets
Applications
  • Diuretic
  • Hypertension Treatment
  • Other
Companies covered
  • ANI Pharma
  • Apeloa Kangyu
  • Cigna
  • Glenmark Pharmaceuticals
  • Servier
  • Supra Chemicals
  • Taj Pharmaceuticals
  • Mylan
  • Shandong Yinfeida Pharmaceutical
  • Suzhou Lixinpharm
  • Teva
  • Lisheng Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Indapamide Sales Value (2021-2032)
  4. 1.2.2 Global Indapamide Sales Volume (2021-2032)
  5. 1.2.3 Global Indapamide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Indapamide Market Dynamics
  1. 2.1 Indapamide Industry Trends
  2. 2.2 Indapamide Industry Drivers
  3. 2.3 Indapamide Industry Opportunities and Challenges
  4. 2.4 Indapamide Industry Restraints
3 Indapamide Market by Company
  1. 3.1 Global Indapamide Company Revenue Ranking in 2025
  2. 3.2 Global Indapamide Revenue by Company (2021-2026)
  3. 3.3 Global Indapamide Sales Volume by Company (2021-2026)
  4. 3.4 Global Indapamide Average Price by Company (2021-2026)
  5. 3.5 Global Indapamide Company Ranking (2024-2026)
  6. 3.6 Global Indapamide Company Manufacturing Base and Headquarters
  7. 3.7 Global Indapamide Company Product Type and Application
  8. 3.8 Global Indapamide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Indapamide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Indapamide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Indapamide Market by Type
  1. 4.1 Indapamide Type Introduction
  2. 4.1.1 1.25 mg Indapamide Tablets
  3. 4.1.2 2.5 mg Indapamide Tablets
  4. 4.2 Global Indapamide Sales Volume by Type
  5. 4.2.1 Global Indapamide Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Indapamide Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Indapamide Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Indapamide Sales Value by Type
  9. 4.3.1 Global Indapamide Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Indapamide Sales Value by Type (2021-2032)
  11. 4.3.3 Global Indapamide Sales Value Share by Type (2021-2032)
5 Indapamide Market by Application
  1. 5.1 Indapamide Application Introduction
  2. 5.1.1 Diuretic
  3. 5.1.2 Hypertension Treatment
  4. 5.1.3 Other
  5. 5.2 Global Indapamide Sales Volume by Application
  6. 5.2.1 Global Indapamide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Indapamide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Indapamide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Indapamide Sales Value by Application
  10. 5.3.1 Global Indapamide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Indapamide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Indapamide Sales Value Share by Application (2021-2032)
6 Indapamide Regional Sales and Value Analysis
  1. 6.1 Global Indapamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Indapamide Sales by Region (2021-2032)
  3. 6.2.1 Global Indapamide Sales by Region: 2021-2026
  4. 6.2.2 Global Indapamide Sales by Region (2027-2032)
  5. 6.3 Global Indapamide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Indapamide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Indapamide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Indapamide Sales Value by Region (2027-2032)
  9. 6.5 Global Indapamide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Indapamide Sales Value (2021-2032)
  12. 6.6.2 North America Indapamide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Indapamide Sales Value (2021-2032)
  15. 6.7.2 Europe Indapamide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Indapamide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Indapamide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Indapamide Sales Value (2021-2032)
  21. 6.9.2 South America Indapamide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Indapamide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Indapamide Sales Value Share by Country, 2025 VS 2032
7 Indapamide Country-level Sales and Value Analysis
  1. 7.1 Global Indapamide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Indapamide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Indapamide Sales by Country (2021-2032)
  4. 7.3.1 Global Indapamide Sales by Country (2021-2026)
  5. 7.3.2 Global Indapamide Sales by Country (2027-2032)
  6. 7.4 Global Indapamide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Indapamide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Indapamide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Indapamide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Indapamide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Indapamide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Indapamide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Indapamide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Indapamide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Indapamide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Indapamide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Indapamide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Indapamide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Indapamide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Indapamide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Indapamide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Indapamide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Indapamide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Indapamide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Indapamide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Indapamide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Indapamide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Indapamide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Indapamide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Indapamide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Indapamide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Indapamide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Indapamide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Indapamide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Indapamide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Indapamide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Indapamide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Indapamide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Indapamide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Indapamide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Indapamide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Indapamide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Indapamide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Indapamide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Indapamide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Indapamide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Indapamide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Indapamide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Indapamide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Indapamide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Indapamide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Indapamide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Indapamide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Indapamide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Indapamide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Indapamide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Indapamide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Indapamide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Indapamide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Indapamide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Indapamide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Indapamide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Indapamide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Indapamide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Indapamide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Indapamide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Indapamide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Indapamide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Indapamide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Indapamide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Indapamide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Indapamide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Indapamide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Indapamide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Indapamide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Indapamide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Indapamide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Indapamide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Indapamide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Indapamide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Indapamide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Indapamide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Indapamide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Indapamide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Indapamide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Indapamide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Indapamide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Indapamide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Indapamide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Indapamide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Indapamide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Indapamide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ANI Pharma
  2. 8.1.1 ANI Pharma Company Information
  3. 8.1.2 ANI Pharma Business Overview
  4. 8.1.3 ANI Pharma Indapamide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ANI Pharma Indapamide Product Portfolio
  6. 8.1.5 ANI Pharma Recent Developments
  7. 8.2 Apeloa Kangyu
  8. 8.2.1 Apeloa Kangyu Company Information
  9. 8.2.2 Apeloa Kangyu Business Overview
  10. 8.2.3 Apeloa Kangyu Indapamide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Apeloa Kangyu Indapamide Product Portfolio
  12. 8.2.5 Apeloa Kangyu Recent Developments
  13. 8.3 Cigna
  14. 8.3.1 Cigna Company Information
  15. 8.3.2 Cigna Business Overview
  16. 8.3.3 Cigna Indapamide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cigna Indapamide Product Portfolio
  18. 8.3.5 Cigna Recent Developments
  19. 8.4 Glenmark Pharmaceuticals
  20. 8.4.1 Glenmark Pharmaceuticals Company Information
  21. 8.4.2 Glenmark Pharmaceuticals Business Overview
  22. 8.4.3 Glenmark Pharmaceuticals Indapamide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glenmark Pharmaceuticals Indapamide Product Portfolio
  24. 8.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 8.5 Servier
  26. 8.5.1 Servier Company Information
  27. 8.5.2 Servier Business Overview
  28. 8.5.3 Servier Indapamide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Servier Indapamide Product Portfolio
  30. 8.5.5 Servier Recent Developments
  31. 8.6 Supra Chemicals
  32. 8.6.1 Supra Chemicals Company Information
  33. 8.6.2 Supra Chemicals Business Overview
  34. 8.6.3 Supra Chemicals Indapamide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Supra Chemicals Indapamide Product Portfolio
  36. 8.6.5 Supra Chemicals Recent Developments
  37. 8.7 Taj Pharmaceuticals
  38. 8.7.1 Taj Pharmaceuticals Company Information
  39. 8.7.2 Taj Pharmaceuticals Business Overview
  40. 8.7.3 Taj Pharmaceuticals Indapamide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Taj Pharmaceuticals Indapamide Product Portfolio
  42. 8.7.5 Taj Pharmaceuticals Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Indapamide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Indapamide Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Shandong Yinfeida Pharmaceutical
  50. 8.9.1 Shandong Yinfeida Pharmaceutical Company Information
  51. 8.9.2 Shandong Yinfeida Pharmaceutical Business Overview
  52. 8.9.3 Shandong Yinfeida Pharmaceutical Indapamide Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio
  54. 8.9.5 Shandong Yinfeida Pharmaceutical Recent Developments
  55. 8.10 Suzhou Lixinpharm
  56. 8.10.1 Suzhou Lixinpharm Company Information
  57. 8.10.2 Suzhou Lixinpharm Business Overview
  58. 8.10.3 Suzhou Lixinpharm Indapamide Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Suzhou Lixinpharm Indapamide Product Portfolio
  60. 8.10.5 Suzhou Lixinpharm Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Indapamide Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Teva Indapamide Product Portfolio
  66. 8.11.5 Teva Recent Developments
  67. 8.12 Lisheng Pharma
  68. 8.12.1 Lisheng Pharma Company Information
  69. 8.12.2 Lisheng Pharma Business Overview
  70. 8.12.3 Lisheng Pharma Indapamide Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lisheng Pharma Indapamide Product Portfolio
  72. 8.12.5 Lisheng Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Indapamide Value Chain Analysis
  2. 9.1.1 Indapamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Indapamide Sales Mode & Process
  6. 9.2 Indapamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Indapamide Distributors
  9. 9.2.3 Indapamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst